The top five scFvs selected from Figure 1C were then incorporated into CD70 CAR-T cells, and the short-term tumor-killing ability of these CD70 CAR-T cells was assessed by co-culturing them with 786-0 cells for 6 hours. The gene discussed is CD70; the disease is neoplasm.